Lei 2013 TNF antagonism improves neurological recovery in murine intracerebral hemorrhage

Complete the Request a Consultation Form or call +1 (561) 353-9707 to request a phone or in-office consultation with an INR medical provider.

Edward Tobinick, M.D., the founder and Director of the Institute of Neurological Recovery, invented the remarkable breakthrough perispinal etanercept treatment for stroke and chronic brain injury, first used in 2010, now with thousands of patients treated from 76 countries.

In October 2018, the Australian Government announced their designation of substantial funding to study perispinal etanercept(PSE) for treatment of stroke. On January 3, 2020 a university, double-blind, randomized, placebo-controlled, clinical trial confirmed the efficacy of perispinal etanercept for treatment of chronic, post-stroke pain. Dr. Tobinick was instrumental in the design of the university study.

The INR accepts patients for treatment from all parts of the world, and has treated patients from every populated continent of the world.

Scientific articles from hundreds of academic scientists around the world have cited INR publications.

Request a consultation here.

More Info